Literature DB >> 19594745

Vascular density in childhood acute lymphoblastic leukaemia correlates to biological factors and outcome.

Ulrika Norén-Nyström1, Mats Heyman, Per Frisk, Irina Golovleva, Christer Sundström, Anna Porwit, Göran Roos, Anders Bergh, Erik Forestier.   

Abstract

The issue of angiogenesis and its clinical relevance in childhood acute lymphoblastic leukaemia (ALL) is controversial. In the present study, microvessel density (MVD), analysed in 185 diagnostic bone marrow biopsies, was higher in T-cell ALL compared to B-cell precursor (BCP)-ALL (P = 0.013). In the BCP group, cases with t(12;21) were characterized by a low MVD while patients with high-hyperdiploid leukaemia (HeH, 51-61 chromosomes) showed a high MVD compared to other BCP patients (P = 0.001 and 0.002 respectively). There was a correlation between MVD and white blood cell (WBC) count in high-risk BCP patients (P = 0.021). In addition, BCP patients with a high marrow reticulin fibre density and high MVD had an unfavourable outcome compared to the other BCP patients (P = 0.002). The fraction of vessels in which lumina were filled with blasts (blast congested vessel fraction) correlated strongly with WBC count (P < 0.001). These findings indicate that the angiogenic process interacts with other stroma-factors, such as reticulin fibre density, in its effect on outcome, and is coupled to both the ALL genotype and phenotype. One possible implication is that different subtypes of childhood ALL may respond differently to anti-angiogenic drugs as a supplement in first-line treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19594745     DOI: 10.1111/j.1365-2141.2009.07796.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Complete blood cell count and retinal vessel diameters.

Authors:  Barbara E K Klein; Ronald Klein; Chelsea E Myers; Kristine E Lee
Journal:  Arch Ophthalmol       Date:  2011-04

2.  Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.

Authors:  Michael Medinger; Natalie Fischer; Alexandar Tzankov
Journal:  J Oncol       Date:  2010-05-24       Impact factor: 4.375

3.  Clinical trials with anti-angiogenic agents in hematological malignancies.

Authors:  Michael Medinger; Klaus Mross
Journal:  J Angiogenes Res       Date:  2010-06-22

4.  What role for angiogenesis in childhood acute lymphoblastic leukaemia?

Authors:  P Schneider; I Dubus; F Gouel; E Legrand; J P Vannier; M Vasse
Journal:  Adv Hematol       Date:  2011-11-09

Review 5.  Leukaemia: a model metastatic disease.

Authors:  Andrew E Whiteley; Trevor T Price; Gaia Cantelli; Dorothy A Sipkins
Journal:  Nat Rev Cancer       Date:  2021-05-05       Impact factor: 69.800

6.  Endothelial PERK-ATF4-JAG1 axis activated by T-ALL remodels bone marrow vascular niche.

Authors:  Cui Liu; Qiuyun Chen; Yinghui Shang; Lechuang Chen; Jay Myers; Amad Awadallah; Jinger Sun; Shuiliang Yu; Katharine Umphred-Wilson; Danian Che; Yingtong Dou; Luoyi Li; Pamela Wearsch; Diana Ramírez-Bergeron; Rose Beck; Wei Xin; Ge Jin; Stanley Adoro; Lan Zhou
Journal:  Theranostics       Date:  2022-03-21       Impact factor: 11.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.